Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors that are activated by fatty acids and their derivatives. The peroxisome proliferator-activated receptors (PPARs) belong to the ligand-inducible nuclear hormone receptor superfamily including three major members: PPARα (also called NR1C1), PPARβ/δ (also called NR1C2), and PPARγ (also called NR1C3). The three subtypes show different expression patterns in vertebrates.
Despite several similarities, each PPAR isoform shows specific functions likely due to different biochemical properties, variable tissue distribution, and differential responses to different ligands. Each of them is encoded in a separate gene and binds fatty acids and eicosanoids.
PPARα plays a role in the clearance of circulating or cellular lipids via the regulation of gene expression involved in lipid metabolism in liver and skeletal muscle. PPAR2α is highly expressed in liver, skeletal muscle, kidney, heart and vascular wall, and relatively low in fat and cartilage.
PPARβ/δ is involved in lipid oxidation and cell proliferation. PPARβ is highly expressed in the brain, stomach and colon.
PPARγ promotes adipocyte differentiation to enhance blood glucose uptake. PPAR gamma was expressed in mammalian adipose tissue, vascular smooth muscle tissue and myocardial tissue.
PPAR transcriptional activity can be modulated through a nongenomic cross talk with phosphatases and kinases, including ERK1/2, p38-MAPK, PKA, PKC, AMPK, and GSK3. PPARs can form heterodimers with retinoid X receptor (RXR) modulating the expression of genes involved in lipid metabolism, adipogenesis, maintenance of metabolic homeostasis, and inflammation and inducing also anticancer effects in a variety of human tumors.
PPARs is an important target of human metabolism-related diseases, and it is involved in regulating energy metabolism, cell differentiation and inflammatory response of peroxidase body proliferation. It is related to many pathophysiological processes such as obesity, insulin resistance, hypertension, T2DM, ankylosing spondylitis (AS) and tumor.
|CD36||CD36 Antibody||CD36 Protein||CD36 cDNA||CD36 ELISA Kit|
|CPT1A||CPT1A Antibody||CPT1A Protein||CPT1A cDNA||CPT1A ELISA Kit|
|CPT1B||CPT1B Antibody||CPT1B Protein||CPT1B cDNA||CPT1B ELISA Kit|
|CPT1C||CPT1C Antibody||CPT1C Protein||CPT1C cDNA||CPT1C ELISA Kit|
|CPT2||CPT2 Antibody||CPT2 Protein||CPT2 cDNA||CPT2 ELISA Kit|
|CYP27A1||CYP27A1 Antibody||CYP27A1 Protein||CYP27A1 cDNA||CYP27A1 ELISA Kit|
|CYP7A1||CYP7A1 Antibody||CYP7A1 Protein||CYP7A1 cDNA||CYP7A1 ELISA Kit|
|CYP8B1||CYP8B1 Antibody||CYP8B1 Protein||CYP8B1 cDNA||CYP8B1 ELISA Kit|
|DBI||DBI Antibody||DBI Protein||DBI cDNA||DBI ELISA Kit|
|EHHADH||EHHADH Antibody||EHHADH Protein||EHHADH cDNA||EHHADH ELISA Kit|
|FABP1||FABP1 Antibody||FABP1 Protein||FABP1 cDNA||FABP1 ELISA Kit|
|FABP2||FABP2 Antibody||FABP2 Protein||FABP2 cDNA||FABP2 ELISA Kit|
|FABP3||FABP3 Antibody||FABP3 Protein||FABP3 cDNA||FABP3 ELISA Kit|
|FABP4||FABP4 Antibody||FABP4 Protein||FABP4 cDNA||FABP4 ELISA Kit|
|FABP5||FABP5 Antibody||FABP5 Protein||FABP5 cDNA||FABP5 ELISA Kit|
|FABP6||FABP6 Antibody||FABP6 Protein||FABP6 cDNA||FABP6 ELISA Kit|
|FABP7||FABP7 Antibody||FABP7 Protein||FABP7 cDNA||FABP7 ELISA Kit|
|FADS2||FADS2 Antibody||FADS2 Protein||FADS2 cDNA||FADS2 ELISA Kit|
|GK||GK Antibody||GK Protein||GK cDNA||GK ELISA Kit|
|GK2||GK2 Antibody||GK2 Protein||GK2 cDNA||GK2 ELISA Kit|